NASH, acute Liver Failure and Comlications of Liver Cirrhosis Non-Alcoholic Steatohepatitis (NASH) - of the Pathophysiology of innovative Treatment

被引：0
|
作者：
Tilg, Herbert [1 ,2 ]
机构：
[1] Med Univ Innsbruck, Abt Innere Med, Innsbruck, Austria
[2] Med Univ Innsbruck, Christian Doppler Forsch Lab Entzundungsbiol, Innsbruck, Austria
来源：
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2010年 / 60卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：713 / 714
页数：2
相关论文
共 50 条
  • [21] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
  • [22] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
  • [23] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127
  • [24] Therapies in non-alcoholic steatohepatitis (NASH)
    Oseini, Abdul M.
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2017, 37 : 97 - 103
  • [25] Liver carcinogenesis in non-alcoholic steatohepatitis (NASH) - Relation to oxidative stress and apoptosis
    Yatsuji, Satoru
    Hashimoto, Etsuko
    Tobari, Maki
    Takakura, Mihoko
    Taniai, Makiko
    Tokushige, Katsutoshi
    Shiratori, Keiko
    Shibata, Noriyuki
    Kobayashi, Makio
    GASTROENTEROLOGY, 2006, 130 (04) : A819 - A819
  • [26] Clinical features commonly associated with fatty liver non-alcoholic steatohepatitis (NASH).
    Badalamenti, S
    Kligerman, S
    Molina, E
    Jeffers, L
    Reddy, R
    Schiff, E
    HEPATOLOGY, 1998, 28 (04) : 385A - 385A
  • [27] Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
    Stefano, J. T.
    Pereira, I. V. A.
    Torres, M. M.
    Bida, P. M.
    Coelho, A. M. M.
    Xerfan, M. P.
    Cogliati, B.
    Barbeiro, D. F.
    Mazo, D. F. C.
    Kubrusly, M. S.
    D'Albuquerque, L. A. C.
    Souza, H. P.
    Carrilho, F. J.
    Oliveira, C. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (05) : 408 - 414
  • [28] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miette, Veronique
    Fournier, Celine
    Adara, Linda
    Sandrin, Laurent
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
  • [29] Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Burra, Patrizia
    Bizzaro, Debora
    Gonta, Anna
    Shalaby, Sarah
    Gambato, Martina
    Morelli, Maria Cristina
    Trapani, Silvia
    Floreani, Annarosa
    Marra, Fabio
    Brunetto, Maurizia Rossana
    Taliani, Gloria
    Villa, Erica
    LIVER INTERNATIONAL, 2021, 41 (08) : 1713 - 1733
  • [30] Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
    Changez, Mah I. Kan
    Mubeen, Maryam
    Zehra, Monezahe
    Samnani, Inara
    Rasool, Aniqa Abdul
    Mohan, Anmol
    Ul Wara, Um
    Tejwaney, Usha
    Kumar, Vikash
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
12345